TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 81 filers reported holding TCR2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -97.4% | 270 | -98.0% | 0.00% | – |
| Q1 2022 | $38,000 | -40.6% | 13,763 | 0.0% | 0.00% | – |
| Q4 2021 | $64,000 | -46.2% | 13,763 | -1.6% | 0.00% | – |
| Q3 2021 | $119,000 | -73.8% | 13,980 | -49.6% | 0.00% | – |
| Q2 2021 | $455,000 | -10.4% | 27,727 | +20.6% | 0.00% | -100.0% |
| Q1 2021 | $508,000 | -28.6% | 22,993 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $711,000 | +133.1% | 22,993 | +53.4% | 0.00% | – |
| Q3 2020 | $305,000 | +32.6% | 14,993 | 0.0% | 0.00% | – |
| Q2 2020 | $230,000 | +132.3% | 14,993 | +17.1% | 0.00% | – |
| Q1 2020 | $99,000 | -45.9% | 12,800 | 0.0% | 0.00% | – |
| Q4 2019 | $183,000 | +90.6% | 12,800 | +100.0% | 0.00% | – |
| Q3 2019 | $96,000 | -4.0% | 6,400 | -8.6% | 0.00% | – |
| Q2 2019 | $100,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |